Background: The adenoma detection rate (ADR) is of primary importance to the quality of screening colonoscopy. An online survey was conducted to assess knowledge and practices on ADR.
METHODS
In total, 250 US gastroenterologists completed a paid electronic survey during February 2018. The survey was sponsored by Aries Pharmaceuticals (San Diego, CA) and distributed by email through Lightspeed (Lightspeed Health, New York, NY) to a random sample of physicians already registered in its database. All respondents were already opted in to receive program invitations affiliated with Lightspeed Health Online. The physicians were screened for eligibility to participate according to criteria established by Aries. Inclusion criteria included: (1) board certified gastroenterologist; (2) > 80 colonoscopies performed per month for screening, surveillance, or diagnosis; and (3) in practice between 3 and 35 years after fellowship. Physicians who completed the survey were paid $30.
The survey consisted of multiple-choice and open-ended questions on physician demographics, general knowledge regarding ADR, physician impressions of ADR, knowledge of devices and methods to improve ADR, and implementation and application of ADR in practice (Supplemental Table 1 , Supplemental Digital Content 1, http://links.lww. com/JCG/A491). While completing the survey, responses to questions previously answered could not be altered at a later time. Individual copies of survey responses were collected by Lightspeed and compiled in an MS Excel spreadsheet. Responses were either coded numerically, that is, "no" = 0 and "yes" = 1 or tabulated by the Aries Pharmaceuticals team based on parameters including general responses, region, and years in practice (YIP). Pivot tables in MS Excel were used to investigate significant associations between the responses and YIP or geographic location.
A χ 2 contingency test (α = 0.05) was used to examine the association between YIP with gender and with the fraction of physicians tracking ADR.
RESULTS

Physician Demographics
Demographic information on the physician participants is summarized in Table 1 . Most (62%) reported performing colonoscopies in a mix of hospitals and ambulatory surgery centers. Among those who performed colonoscopies in both settings, 76% indicated performing the majority of colonoscopies in an ambulatory surgery center. The most common practice type was private group (66%), followed by academic group (22%) and private solo practitioner (12%). Respondents were 80% male. The fraction who were female decreased with increasing YIP (P < 0.0001; Supplemental Table 2 , Supplemental Digital Content 1, http://links.lww. com/JCG/A491). The geographic location of the physician sample was 19% midwest, 20% west, 30% northeast, and 31% south. There were no significant differences in answers by geographic location.
General Knowledge Regarding ADR
On the basis of an open-ended question asking the physicians to provide a definition of ADR, 51% were able to provide an accurate definition, including the distinction that ADR applies to screening colonoscopies ( Table 2 ). Another 39% understood that ADR defines the fraction of colonoscopy patients with a detected adenoma, but did not specify the screening restriction. In total, 76% incorrectly answered that ADR should reflect patients who also have sessile-serrated polyps/adenomas (see below). Table 3 summarizes the responses to questions testing knowledge about the 2017 US MSTF CRC screening recommendations that concern ADR. 20 In total, 37% of respondents correctly answered that the recommended minimum acceptable ADR threshold is ≥ 25%. A large fraction believed incorrectly that the threshold is determined by a national ADR average of 25% (51%), a majority of whom stipulated that the ADR threshold also depended on the patient population. Only 46% of respondents knew current recommendations are for patients to ask prospective colonoscopists for their ADR. The majority of respondents (78%) correctly answered that cecal intubation should be ≥ 95% for screening colonoscopies and correctly knew that the age to begin screening for average-risk patients in the MSTF recommendations was not reduced to 45 years old (83%). The majority of the physicians correctly answered that increasing one's ADR can decrease interval cancer rates (77%) and that increased ADR is correlated with decreased CRC deaths (67%).
Importance of ADR
When asked about the importance of a physician's ADR in a colonoscopy screening, 75% of respondents responded with a score of ≥ 8 on a scale of 1 to 10 ( Fig. 1 ). In total, 62% of physicians also reported that a high ADR is an indication of a quality colonoscopy (Supplemental Table 3 , Supplemental Digital Content 1, http://links.lww. com/JCG/A491).
Devices and Techniques for Improving ADR
Presented with a limited sample of devices and techniques that could be utilized during colonoscopy to improve ADR, respondents answered that caps and chromoendoscopy were the most important tools (Fig. 2) . In contrast, high-definition (HD) colonoscopes and education were not seen as important means for improving ADR. Additional open-ended responses showed that good bowel preparation was considered very important for increasing ADR (Supplemental Table 4 , Supplemental Digital Content 1, http:// links.lww.com/JCG/A491).
Measurement and Sharing of ADR
Overall, 80% of physicians reported tracking their individual ADRs. Of these, 83% were able to report their actual ADR, summarized in Figure 3A . Some of these responses were not compatible with a correctly measured ADR, as they exceeded any previously reported ADR levels in true screening populations (Fig. 3A) . Among physicians that do not track their ADR, 35% reported that a busy practice is the main factor preventing them from doing so (Fig. 3B) . When asked what would influence them to begin tracking their ADR, physicians reported that they would do so if it were required for reimbursement (34%) or became easier to measure (31%) (Fig. 3C ). There was a trend showing lower ADR tracking among physicians with greater YIP after fellowship, but the association was not significant (P = 0.10; Supplemental Table 5 , Supplemental Digital Content 1, http://links. lww.com/JCG/A491).
Most physicians (57%) reported they do not share ADR information with their patients (Table 4 ). Common reasons for not sharing ADR were that patients do not ask for it (28%) and that sharing ADR is not required (21%).
Barriers to Increasing ADR
The most common barrier to increasing ADR reported by 68% of the physicians is a lack of time ( Fig. 4) . Approximately 40% of the physicians also reported the cost of devices, training, and resources required were also barriers to increasing ADR (Fig. 4 ).
Fraction of Patients Requesting ADR
Over half of the physicians (59%) indicated that none of their patients have asked for their individual ADRs over the last 6 months.
DISCUSSION
We describe the results of a paid internet survey of gastroenterologists regarding their knowledge and measurement of the ADR. Measurement of the ADR has been recommended by the US MSTF since 2002, 13 by a joint task force of the ACG-ASGE since 2006, 14 and has been validated as a predictor of interval cancers in 2 large studies. 12, 16 However, there is little information concerning how widespread measurement of ADR is among US gastroenterologists. Many insurers do not mandate measurement of ADR. Measurement is largely enforced by institutions and practices that utilize colonoscopy. Several programs encourage and/or facilitate measurement of ADR, such as GIQuic 21 and inclusion of ADR as an accepted measure in the Physician's Quality Reporting System. However, many physicians anecdotally are not measuring ADR, despite its proven value as a predictor of interval cancers.
In total, 80% of gastroenterologists participating in the paid exercise reported that they measure ADR, and a similar fraction responded that ADR measurement is very important. However, some respondents reported ADRs that were above 70%, a result that has not been described previously in pure screening populations. [21] [22] [23] Nevertheless, the large fraction of gastroenterologists who consider ADR as important and the large number of ADRs that were similar to those reported by GIQuic 21 is encouraging, and suggests that ADR has become an important aspect of colonoscopy practice in the United States.
Our results suggest that ADR is frequently not measured correctly. In particular, a substantial fraction of respondents did not restrict measurement of ADR to screening colonoscopy, as recommended by the ACG-ASGE Task Force. 15 However, a recent study found that including all colonoscopies in patients age 50 and older not performed in inflammatory bowel disease or polyposis patients, gives an ADR result similar to ADR in screening patients only. Therefore, it may not be critical to confine ADR measurement to screening patients. 24 Indeed, the original presentation of ADR by the MSTF did not restrict the measure to screening patients. 13 A second misconception from many respondents was that the ADR measurement should include sessile-serrated impact on patient behavior. This is understandable, given that it may be uncomfortable for the patient to ask this question. Additional efforts are needed to make a physician's colonoscopy performance more transparent.
Our survey asked physicians about their knowledge of devices and techniques that could increase ADR. A number of techniques were not presented to the survey participants, including Endocuff, 26, 27 EndoRings, 28, 29 and electronic chromoendoscopy. [30] [31] [32] [33] Thus, only selected information was presented. However, trends in the answers suggested that gastroenterologists' understanding of the utility of the presented approaches was poor. For example, HD colonoscopes were considered less valuable than caps on the colonoscope tip. However, meta-analyses show that HD colonoscopy increases ADR by 2% to 4%, 34 and HD colonoscopy is generally considered essential to modern therapeutic colonoscopy. In contrast, meta-analyses 30 indicate that a short cap or hood on the colonoscope tip is not beneficial for increasing ADR. Similarly, education was considered to have less importance than both caps and chromoendoscopy, though available evidence indicates that education on withdrawal technique and the appearance of subtle colorectal neoplasia have a substantial positive impact on detection. 35, 36 Chromoendoscopy was rated by the physicians as being relatively valuable, similar to caps. Gastroenterologists were correct in placing substantial value on chromoendoscopy, as meta-analyses, 30, 37 as well as the largest randomized controlled trials 23, 38 indicate that chromoendoscopy can improve the detection of conventional adenomas, sessile-serrated polyps, and potentially advanced adenomas. Again, the survey results suggest that additional work is needed to improve gastroenterologists' understanding of effective adjuncts to detection.
Limitations of the survey are several. First, the survey was paid, and was open only to participants in the Lightspeed Health Database. Thus, these gastroenterologists may not be representative of the full spectrum of gastroenterologists performing colonoscopy in the United States. Our sample did include a large number of community gastroenterologists, and gastroenterologists from across the United States. Generally, no important differences were seen by region, or by academic versus community practice. Further, our survey relied on self-reporting. We were not able to require that gastroenterologists present convincing evidence that they actually measure their ADR. However, our survey does supply evidence that ADR measurement by gastroenterologists in the United States is incomplete, that the measurement is likely to have some degree of inaccuracy in its application, and that there is a significant element of inadequate knowledge regarding ADR and effective tools to improve ADR.
In conclusion, ADR is widely considered an important quality measurement in colonoscopy, and most practicing colonoscopists in the United States recognize and acknowledge the importance of ADR. A substantial fraction of US gastroenterologists claim to be measuring their ADR, though our survey results suggest significant knowledge deficits regarding the precise definition of ADR, as well as deficits in understanding which methods to improve ADR are effective. We recommend that additional surveys of ADR measurement and ADR understanding be undertaken, and that ongoing efforts to educate colonoscopists on the value of ADR and tools to improve ADR continue. 
